Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapyA Belldegrun, W Pierce, D Sayah, et al.
The Journal of Urology|March 1, 1991
The effects of interleukin-6 on tumor-infiltrating lymphocytes derived from human renal cell cancerT Y Lee, A S Koo, C Peyret, et al.
Gene Therapy|September 26, 2001
Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectorsL Wu, J Matherly, A Smallwood, et al.
Microsurgery|January 1, 1993
Effect of caval-portal shunt on ovarian tissue in rats: I. Histological observationD Y Chung, L Mao, M D'Silva, et al.
The Journal of Urology|March 29, 2000
Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteriaK H Tsui, O Shvarts, R B Smith, et al.
Clinical Nephrology|September 1, 1988
Metabolic and renal effects of interleukin-2 immunotherapy for metastatic cancerD E Webb, H A Austin, A Belldegrun, et al.
The Journal of Urology|July 2, 1998
Positron emission tomography in urological oncologyC K Hoh, M A Seltzer, J Franklin, et al.
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patientsR Figlin, B Gitlitz, J Franklin, et al.
The Journal of Surgical Research|December 1, 1992
Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinomaC Peyret, B H Bochner, T Y Lee, et al.
The Journal of Urology|January 27, 2000
Renal cell carcinoma: prognostic significance of incidentally detected tumorsK H Tsui, O Shvarts, R B Smith, et al.
Pageof 19